Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Effects of uric acid on ischemic diseases, stratified by lipid levels: a drug-target, nonlinear Mendelian randomization study ; volume:14 ; number:1 ; day:16 ; month:1 ; year:2024 ; pages:1-7 ; date:12.2024
Scientific reports ; 14, Heft 1 (16.1.2024), 1-7, 12.2024
- Creator
-
Kim, Jungeun
Lee, Sun Yeop
Lee, Jihye
Yoon, Sanghyuk
Kim, Eun Gyo
Lee, Eunbyeol
Kim, Nayoung
Lee, Sol
Gym, Ho
Park, Sang-In
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-51724-1
- URN
-
urn:nbn:de:101:1-2024032722205781845446
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:55 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kim, Jungeun
- Lee, Sun Yeop
- Lee, Jihye
- Yoon, Sanghyuk
- Kim, Eun Gyo
- Lee, Eunbyeol
- Kim, Nayoung
- Lee, Sol
- Gym, Ho
- Park, Sang-In
- SpringerLink (Online service)
Other Objects (12)
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis
Investigating the causal association between serum uric acid levels and gastric cancer risk: a Mendelian randomization study
Avoiding collider bias in Mendelian randomization when performing stratified analyses
Lipid-lowering drugs and inflammatory bowel disease’s risk: a drug-target Mendelian randomization study
Causality between serum uric acid and diabetic microvascular complications - a mendelian randomization study
New evidence: Metformin unsuitable as routine adjuvant for breast cancer: a drug-target mendelian randomization analysis
Assessing the safety of lipid-modifying medications among Chinese adolescents: a drug-target Mendelian randomization study
A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism
Effects of genetically proxied lipid-lowering drugs on acute myocardial infarction: a drug-target mendelian randomization study
Uric acid and risk of gestational diabetes mellitus: an observational study and mendelian randomization analysis
Genetic proxies for therapy of insulin drug targets and risk of osteoarthritis: a drug-target Mendelian randomization analysis
Exploring the causal effect between lipid-modifying drugs and idiopathic pulmonary fibrosis: a drug-target Mendelian randomization study
Causal relationships between GLP1 receptor agonists, blood lipids, and heart failure: a drug-target mendelian randomization and mediation analysis